Dynorphin A (1-13) for High-Throughput KOR Screening
HPLC-Polished Dynorphin A (1-13) with <0.5% D-Isomer Impurities for Reproducible KOR EC50 in Automated Plate Readers
In high-throughput screening (HTS) campaigns targeting the kappa opioid receptor (KOR), the consistency of the pharmacological response is paramount. As a pharmaceutical intermediate and research grade peptide, Dynorphin A (1-13) must meet stringent purity criteria to ensure that observed EC50 shifts are due to the test compounds, not batch-to-batch variability in the agonist. At NINGBO INNO PHARMCHEM, we have optimized our synthesis and purification protocols to deliver Dynorphin A (1-13) with a total purity exceeding 98% by HPLC, and critically, with D-isomer impurities controlled to below 0.5%. This specification is not a standard marketing claim; it is a direct response to feedback from screening facilities where even trace levels of diastereomers can cause significant rightward shifts in dose-response curves, leading to false negatives in antagonist screens.
Our process, which can be considered a drop-in replacement for legacy suppliers like Sigma D7017, focuses on the complete removal of deletion sequences and epimerized byproducts. The amino acid sequence of Dynorphin A (1-13), H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-OH, contains multiple basic residues that complicate purification. We employ a two-step HPLC polishing method using orthogonal selectivity (C18 followed by a polar-embedded phase) to resolve the critical pair of [D-Leu5]-Dynorphin A (1-13) from the desired all-L peptide. For laboratories transitioning from the discontinued GenScript product or seeking a reliable alternative to MedChemExpress, our material is qualified to produce a KOR EC50 in the low nanomolar range with a coefficient of variation below 10% across multiple production batches. For a detailed comparison of chromatographic performance, see our technical note on resolving HPLC peak tailing in Dynorphin A (1-13).
Mass Spectrometry Validation of Isobaric Interference Removal in Microtiter Binding Assays
While HPLC-UV at 214 nm provides a necessary purity assessment, it is insufficient to guarantee the absence of isobaric interferences that can plague radioligand binding and functional assays. A common field observation is that certain deletion peptides, such as des-Arg7-Dynorphin A (1-13), co-elute with the main peak under standard gradient conditions but exhibit drastically reduced receptor affinity. To address this, every batch of our Dynorphin A (1-13) is subjected to high-resolution mass spectrometry (HRMS) with a mass accuracy of <3 ppm. The target monoisotopic mass for [M+3H]3+ is 536.64 m/z. We specifically monitor for the presence of the des-Arg7 impurity, which would appear as a +1 Da shift in the isotopic envelope, and for oxidized methionine if the sequence were extended, though our fragment lacks methionine.
For researchers using automated microtiter binding assays, we recommend verifying the peptide stock concentration by quantitative amino acid analysis (AAA) rather than relying solely on gravimetric measurement, as the peptide synthesis process can yield variable counter-ion and water content. Our batch-specific certificate of analysis (COA) includes the net peptide content determined by AAA, ensuring that the calculated EC50 is based on the actual active peptide concentration. This level of quality assurance is essential when comparing data across screening campaigns. For German-speaking clients, we also provide documentation aligned with their requirements, as detailed in our article on Drop-In-Ersatz für Sigma D7017.
Batch-Specific COA Parameters: Purity, Water Content, and Counter-Ion Analysis for High-Throughput Screening
To facilitate seamless integration into automated HTS workflows, our COA reports a comprehensive set of parameters beyond simple HPLC purity. The table below summarizes the typical specifications for our Dynorphin A (1-13) product, which is supplied as a lyophilized powder.
| Parameter | Specification | Analytical Method |
|---|---|---|
| HPLC Purity | ≥98.0% | RP-HPLC at 214 nm |
| D-Isomer Content | <0.5% | Chiral derivatization & HPLC |
| Water Content (Karl Fischer) | ≤8.0% | Coulometric KF titration |
| Counter-Ion (TFA) | 10.0–25.0% | Ion chromatography |
| Net Peptide Content | ≥75.0% | Amino acid analysis |
| Mass Identity | 1603.9 ± 1.0 Da | ESI-HRMS |
Please refer to the batch-specific COA for exact values. A critical non-standard parameter we monitor is the tendency of Dynorphin A (1-13) to form gels in aqueous stock solutions at concentrations above 1 mM, particularly if the pH is adjusted to neutrality with phosphate buffer. This behavior, stemming from the peptide's amphiphilic character, can lead to inaccurate liquid handling in acoustic dispensers. We recommend preparing stock solutions in 10 mM acetic acid (pH ~3.5) and verifying the absence of particulates by dynamic light scattering before dilution into assay buffer. This hands-on knowledge prevents costly downtime in screening robotics.
Bulk Packaging and Stability Data for Long-Term KOR Screening Campaigns
For large-scale screening initiatives, we offer Dynorphin A (1-13) in bulk quantities with packaging optimized for stability and ease of use. Standard formats include 1 mg, 10 mg, and 100 mg aliquots in glass vials under argon. For campaigns requiring kilogram-scale supply, we can provide the peptide in 210L drums or IBC totes as a concentrated solution, though lyophilized powder is recommended for maximum shelf life. Our accelerated stability studies indicate that the lyophilized peptide retains >95% purity after 24 months at -20°C, with no detectable increase in D-isomer content. We advise against repeated freeze-thaw cycles of stock solutions; instead, single-use aliquots should be prepared and stored at -80°C.
As a global manufacturer, we understand the logistical challenges of maintaining a cold chain for temperature-sensitive biochemical standard materials. Our shipping protocols use validated insulated containers with temperature monitors for all orders, ensuring that the peptide arrives in optimal condition regardless of destination. For researchers developing opioid peptide ligand libraries, we can also provide custom synthesis of Dynorphin A fragment analogs with modifications such as N-terminal acetylation or C-terminal amidation. Our production capacity and flexible packaging make us a reliable partner for both exploratory research and preclinical development.
Frequently Asked Questions
What purity grade of Dynorphin A (1-13) is required for high-throughput KOR screening?
For reproducible results in automated plate readers, we recommend a minimum HPLC purity of 98% with D-isomer content below 0.5%. Lower purity grades may contain epimerized or truncated sequences that act as partial agonists or antagonists, skewing EC50 determinations. Our product is specifically polished to meet these stringent HTS requirements.
How can I verify the quality of Dynorphin A (1-13) using mass spectrometry?
High-resolution mass spectrometry (HRMS) is essential to confirm the correct monoisotopic mass and detect isobaric impurities. The [M+3H]3+ ion should appear at m/z 536.64. We recommend examining the isotopic distribution for any deviation that could indicate a deletion sequence, such as des-Arg7. Our COA includes the raw HRMS spectrum for each batch.
Can Dynorphin A (1-13) interfere with fluorescent or luminescent assay readouts?
The peptide itself does not exhibit intrinsic fluorescence, but if the stock solution is not properly filtered, aggregates can scatter light and cause artifacts in fluorescence polarization or TR-FRET assays. We recommend centrifugation at 13,000 × g for 10 minutes before dilution and using a 0.22 µm filter for all stock solutions. Additionally, the TFA counter-ion can affect cellular assays; we offer a TFA removal service upon request.
What is the recommended storage condition for long-term stability?
Lyophilized Dynorphin A (1-13) should be stored at -20°C in a desiccated environment. Under these conditions, we guarantee stability for 24 months from the date of manufacture. Once reconstituted, the peptide solution is stable for one week at 4°C or for up to six months when aliquoted and stored at -80°C. Avoid repeated freeze-thaw cycles.
Sourcing and Technical Support
As a dedicated manufacturer of research grade peptides, NINGBO INNO PHARMCHEM provides comprehensive technical support to ensure the success of your KOR screening programs. Our team can assist with solubility optimization, custom formulation, and analytical method transfer. We maintain a large inventory of Dynorphin A (1-13) to support both small-scale validation and bulk orders, with competitive bulk price options for annual contracts. To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.